Three-Dimensional Quantitative Tumor Response and Survival Analysis of Hepatocellular Carcinoma Patients Who Failed Initial Transarterial Chemoembolization: Repeat or Switch Treatment?
Yan ZhaoReham R HarounSonia SahuRuediger E SchernthanerSusanne SmolkaMing-De LinKelvin K HongChristos GeorgiadesRafael DuranPublished in: Cancers (2022)
Our study quantitatively demonstrated that a second TACE can be beneficial in terms of tumor response and survival for HCC patients who do not initially respond to TACE.